Johnson & Johnson’s COVID vaccine can be approved in two weeks
The first single-dose COVID-19 vaccine could get emergency approval in just two weeks, said Dr. Anthony Fauci on late Friday.
“I would be surprised if the data were analyzed and decisions made in more than two weeks,” Fauci said during an appearance on The Rachel of the vaccine, which was developed by Johnson & Johnson of the New Jersey Maddow Show. “
“We’ll look at the data and see if it’s available to the public,” said Fauci. “So they can go to the FDA to see if they can get an emergency clearance.”
According to Fauci, the U.S. government was working with various companies on six vaccine candidates, two of which have already received emergency approval, one from Pfizer and the other from Moderna. These two require cold storage and two cans.
The J&J vaccine doesn’t necessarily need to be kept super cold, Fauci said, and only takes one dose. These factors will make a huge difference in your ability to get the shots off people, he said. “It offers a wider range of flexibility,” he said.
Johnson & Johnson has announced that it will have 100 million cans available by April.
Any additional vaccines made available will give the city and state a boost that is running out of doses when New Yorkers look for vaccination dates. Mayor Bill de Blasio wrote a letter to President Joe Biden Friday asking for more vaccine deliveries.